ANXA1 and colorectal carcinoma: Interestingly, ANXA1 expression exhibits a moderate to strong positive association with neutrophils, macrophages, and DCs and a weak to moderate association with B cells and T cell subsets (CD4+ and CD8+) [128], supporting ANXA1’s value as a potential biomarker for CRC immune landscape characterization.